134 related articles for article (PubMed ID: 12057698)
1. The incidence of end-stage renal failure in 17 years of heart transplantation: a single center experience.
Satchithananda DK; Parameshwar J; Sharples L; Taylor GJ; McNeil K; Wallwork J; Large SR
J Heart Lung Transplant; 2002 Jun; 21(6):651-7. PubMed ID: 12057698
[TBL] [Abstract][Full Text] [Related]
2. End-stage renal failure and cardiac mortality after heart transplantation.
Sénéchal M; Dorent R; du Montcel ST; Ghossou JJ; Pavie A; Petitclerc T; Dubois M; Isnard R; Gandjbakhch I
Clin Transplant; 2004 Feb; 18(1):1-6. PubMed ID: 15108764
[TBL] [Abstract][Full Text] [Related]
3. End-stage renal disease after orthotopic heart transplantation: a single-institute experience.
Chen YC; Chou NK; Hsu RB; Chi NH; Wu IH; Chen YS; Yu HY; Huang SC; Wang CH; Tsao CI; Ko WJ; Wang SS
Transplant Proc; 2010 Apr; 42(3):948-51. PubMed ID: 20430213
[TBL] [Abstract][Full Text] [Related]
4. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
5. Chronic kidney disease after heart transplantation.
Hamour IM; Omar F; Lyster HS; Palmer A; Banner NR
Nephrol Dial Transplant; 2009 May; 24(5):1655-62. PubMed ID: 19168463
[TBL] [Abstract][Full Text] [Related]
6. Treatment of end-stage renal failure after heart transplantation.
Frimat L; Villemot JP; Cormier L; Cao-Huu T; Renoult E; Hestin D; Dopff C; Mattéi S; Hubert J; Kessler M
Nephrol Dial Transplant; 1998 Nov; 13(11):2905-8. PubMed ID: 9829499
[TBL] [Abstract][Full Text] [Related]
7. The impact of transforming growth factor-beta1 gene polymorphism on end-stage renal failure after heart transplantation.
van de Wetering J; Weimar CH; Balk AH; Roodnat JI; Holweg CT; Baan CC; van Domburg RT; Weimar W
Transplantation; 2006 Dec; 82(12):1744-8. PubMed ID: 17198270
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience.
Ayar Y; Ersoy A; Ocakoglu G; Yildiz A; Oruc A; Soyak H; Calapkulu M; Sahin AB; Topal NB; Okeer E; Coskun B; Kaygisiz O; Kordan Y; Vuruskan H
Transplant Proc; 2017 Mar; 49(2):270-277. PubMed ID: 28219583
[TBL] [Abstract][Full Text] [Related]
9. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment.
Gonwa TA; Mai ML; Melton LB; Hays SR; Goldstein RM; Levy MF; Klintmalm GB
Transplantation; 2001 Dec; 72(12):1934-9. PubMed ID: 11773892
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression.
Goldstein DJ; Zuech N; Sehgal V; Weinberg AD; Drusin R; Cohen D
Transplantation; 1997 Mar; 63(5):664-8. PubMed ID: 9075835
[TBL] [Abstract][Full Text] [Related]
11. Poor prognosis of heart transplant patients with end-stage renal failure.
Villar E; Boissonnat P; Sebbag L; Hendawy A; Cahen R; Trolliet P; Labeeuw M; Ecochard R; Pouteil-Noble C
Nephrol Dial Transplant; 2007 May; 22(5):1383-9. PubMed ID: 17267535
[TBL] [Abstract][Full Text] [Related]
12. The natural history of renal function following orthotopic heart transplant.
Al Aly Z; Abbas S; Moore E; Diallo O; Hauptman PJ; Bastani B
Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
14. Incidence of malignant neoplasia after heart transplantation--a comparison between cyclosporine a and tacrolimus.
Fuchs U; Klein S; Zittermann A; Ensminger SM; Schulz U; Gummert JF
Ann Transplant; 2014 Jun; 19():300-4. PubMed ID: 24953848
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
Zhu L; Ding T; Wang XX; Lin ZB; Chen G
Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients.
Kuo PC; Luikart H; Busse-Henry S; Hunt SA; Valantine HA; Stinson EB; Oyer PE; Scandling JD; Alfrey EJ; Dafoe DC
Clin Transplant; 1995 Apr; 9(2):92-7. PubMed ID: 7599409
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and side-effects of cyclosporine dose monitoring with levels 6 h after the morning dose in heart transplant patients.
Cantarovich M; Besner JG; Fitchett DH; Latter DA
Clin Transplant; 1997 Oct; 11(5 Pt 1):399-405. PubMed ID: 9361930
[TBL] [Abstract][Full Text] [Related]
18. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
Canadian Neoral Renal Transplantation Study Group
Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295
[TBL] [Abstract][Full Text] [Related]
19. Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India.
Agarwal SK; Bhowmik D; Mahajan S; Bagchi S
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27775825
[TBL] [Abstract][Full Text] [Related]
20. Late reduction in cyclosporine dosage does not improve renal function in pediatric heart transplant recipients.
Rice JE; Shipp AT; Carlin JB; Vidmar SI; Weintraub RG
J Heart Lung Transplant; 2002 Oct; 21(10):1109-12. PubMed ID: 12398876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
